Ceramide in cerebrovascular diseases
Ceramide, a bioactive sphingolipid, serves as an important second messenger in cell signal transduction. Under stressful conditions, it can be generated from de novo synthesis, sphingomyelin hydrolysis, and/or the salvage pathway. The brain is rich in lipids, and abnormal lipid levels are associated...
Main Authors: | Huiqi Yuan, Bin Zhu, Cao Li, Zhigang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-06-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2023.1191609/full |
Similar Items
-
Exploring the potential benefits of anthocyanins for individuals with cerebral small vessel disease
by: Taufik Mesiano, et al.
Published: (2024-07-01) -
Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction
by: Nadia Akhiyat, et al.
Published: (2022-04-01) -
Microglial autophagy in cerebrovascular diseases
by: Man Chen, et al.
Published: (2022-10-01) -
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
by: Antía Custodia, et al.
Published: (2021-06-01) -
Cerebrovascular disease in pediatric patients
by: Rotta Newra Tellechea, et al.
Published: (2002-01-01)